ClinicalTrials.Veeva

Menu

Comparison of TIVA (Total Intravenous Anesthesia) and TIVA Plus Palonosetron in Preventing Postoperative Nausea and Vomiting

I

Incheon St.Mary's Hospital

Status

Completed

Conditions

Postoperative Nausea and Vomiting

Treatments

Drug: Total intravenous anesthesia
Drug: Total intravenous anesthesia plus palonosetron

Study type

Interventional

Funder types

Other

Identifiers

NCT01478165
OC11MISI0090

Details and patient eligibility

About

A total intravenous anesthesia (TIVA) is a useful anesthetic technique that reduces the incidence of postoperative nausea and vomiting (PONV).

Investigator hypothesized the incidence of PONV can be further reduced when palonosetron is added to TIVA.

Enrollment

100 patients

Sex

Female

Ages

19+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • ASA Physical Status 1 or 2
  • Elective gynaecological laparoscopic surgery of ≥ 1h duration

Exclusion criteria

  • Anti-emetics, steroids, or psychoactive medications within 24 h of study initiation
  • Vomiting or retching in the 24 h preceding surgery
  • Cancer chemotherapy within 4 weeks or emetogenic radiotherapy within 8 weeks before study entry
  • Ongoing vomiting from gastrointestinal disease

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

100 participants in 2 patient groups, including a placebo group

Tiva group (Group T)
Placebo Comparator group
Treatment:
Drug: Total intravenous anesthesia
TIVA plus palonosetron group (Group T+P)
Active Comparator group
Treatment:
Drug: Total intravenous anesthesia plus palonosetron

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems